164 related articles for article (PubMed ID: 22146869)
1. Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.
Jaremko JL; MacMahon PJ; Torriani M; Merker VL; Mautner VF; Plotkin SR; Bredella MA
Skeletal Radiol; 2012 Aug; 41(8):917-23. PubMed ID: 22146869
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
[TBL] [Abstract][Full Text] [Related]
3. Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.
Cai W; Kassarjian A; Bredella MA; Harris GJ; Yoshida H; Mautner VF; Wenzel R; Plotkin SR
Radiology; 2009 Mar; 250(3):665-73. PubMed ID: 19244040
[TBL] [Abstract][Full Text] [Related]
4. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
5. Value of whole-body magnetic resonance imaging for screening multifocal osteonecrosis in patients with polymyositis/dermatomyositis.
Zhen-Guo H; Min-Xing Y; Xiao-Liang C; Ran Y; He C; Bao-Xiang G; Li-Guo Y; Kai-Ning S; Chan Q; Guo-Chun W
Br J Radiol; 2017 May; 90(1073):20160780. PubMed ID: 28355130
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Multiparametric Whole-Body Magnetic Resonance Imaging over Whole-Spine Magnetic Resonance Imaging in Patients with Neurofibromatosis Type I.
Zhang L; Dessouky R; Xi Y; Chhabra A; Le LQ
World Neurosurg; 2017 Dec; 108():729-737. PubMed ID: 28939538
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
8. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
[TBL] [Abstract][Full Text] [Related]
9. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.
Ahlawat S; Fayad LM; Khan MS; Bredella MA; Harris GJ; Evans DG; Farschtschi S; Jacobs MA; Chhabra A; Salamon JM; Wenzel R; Mautner VF; Dombi E; Cai W; Plotkin SR; Blakeley JO; ;
Neurology; 2016 Aug; 87(7 Suppl 1):S31-9. PubMed ID: 27527647
[TBL] [Abstract][Full Text] [Related]
10. Schwannomatosis: a genetic and epidemiological study.
Evans DG; Bowers NL; Tobi S; Hartley C; Wallace AJ; King AT; Lloyd SKW; Rutherford SA; Hammerbeck-Ward C; Pathmanaban ON; Freeman SR; Ealing J; Kellett M; Laitt R; Thomas O; Halliday D; Ferner R; Taylor A; Duff C; Harkness EF; Smith MJ
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1215-1219. PubMed ID: 29909380
[TBL] [Abstract][Full Text] [Related]
11. Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis.
Smith MJ; Esparza S; Merker VL; Muzikansky A; Bredella MA; Harris GJ; Kassarjian A; Cai W; Walker JA; Mautner VF; Plotkin SR
Clin Biochem; 2013 May; 46(7-8):698-700. PubMed ID: 23261835
[TBL] [Abstract][Full Text] [Related]
12. Scoliosis in Neurofibromatosis Type 1 on Whole-Body Magnetic Resonance Imaging: Frequency and Association With Intraspinal and Paraspinal Tumors.
Haider S; Le LQ; Cho G; Xi Y; Chhabra A
J Comput Assist Tomogr; 2022 Mar-Apr 01; 46(2):231-235. PubMed ID: 35297579
[TBL] [Abstract][Full Text] [Related]
13. Added Value of Contrast-Enhanced T1-Weighted and Diffusion-Weighted Sequences for Characterization of Incidental Findings on Whole Body Magnetic Resonance Imaging in Plasma-Cell Disorders.
Westerland O; Sivarasan N; Natas S; Verma H; McElroy S; Winfield JM; Neji R; El-Najjar I; Kazmi M; Streetly M; Goh V
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):822-828. PubMed ID: 30219657
[TBL] [Abstract][Full Text] [Related]
14. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
[TBL] [Abstract][Full Text] [Related]
15. Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management.
Hegenscheid K; Seipel R; Schmidt CO; Völzke H; Kühn JP; Biffar R; Kroemer HK; Hosten N; Puls R
Eur Radiol; 2013 Mar; 23(3):816-26. PubMed ID: 22911290
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study.
Schmidt CO; Hegenscheid K; Erdmann P; Kohlmann T; Langanke M; Völzke H; Puls R; Assel H; Biffar R; Grabe HJ
Eur Radiol; 2013 May; 23(5):1343-51. PubMed ID: 23239059
[TBL] [Abstract][Full Text] [Related]
17. Schwannomatosis: a new member of neurofibromatosis family.
Chen SL; Liu C; Liu B; Yi CJ; Wang ZX; Rong YB; Zhu J; Ding Y; Tian GL
Chin Med J (Engl); 2013 Jul; 126(14):2656-60. PubMed ID: 23876891
[TBL] [Abstract][Full Text] [Related]
18. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of schwannomatosis: a retrospective analysis of 87 patients.
Merker VL; Esparza S; Smith MJ; Stemmer-Rachamimov A; Plotkin SR
Oncologist; 2012; 17(10):1317-22. PubMed ID: 22927469
[TBL] [Abstract][Full Text] [Related]
20. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
